Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

Université Laval

$188,342.00

PhysioLens: a novel technology to standardize and democratize respiratory research on lung tissue

EF 2022-23

Résumé
Since the lung is the organ most affected by COVID-19, an increasing number of scientists across the world, with or without specialized knowledge in pulmonology, are searching for means to study the lung tissue using an efficient, biologically-relevant and cost-effective approach. Although this represents a huge engineering challenge, SCIREQ, a Canadian company specialized in respiratory equipment, is rising to the challenge. It is fabricating a new technology, called the physioLens, that is now in the final stages of development and that will enable any scientist to readily undertake experimental studies on isolated lung tissue. SCIREQ is now working with the team of Dr Ynuk Bossé, professor at Laval University and experts in lung physiology, to: 1- optimize, standardize and automate the procedures; 2- undertake validation studies to confirm the usefulness of the technology; and 3- develop new systems to increase the physioLens' versatility and applicability.While enabling the final adjustments before commercialization, this project will also extend the physioLens' capabilities with highly sought-after features that can turn out to be real game changers in respiratory research. This new technology will offer an unprecedented means to study lung tissue in an accurate and reproducible fashion, expediting progress and allowing comparisons between results obtained in different laboratories.In the short term, the physioLens is essential for any scientist seeking a validated and accessible means to study lung tissue. In the long term, it may enable breakthroughs with significant impacts, including the potential to improve patients' care and save lives by accelerating research and drug discovery on COVID-19. Additionally, it will promote a Canadian company, strengthen the link between the academic and private sectors, train highly qualified personnel, keep Canadian lung physiologists at the leading-edge of their field, and contribute to Canada's economic recovery from the pandemic.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
570485-2021
Name nom
Bossé, Ynuk YH
Department département
Médecine
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2021
Award amount
188342
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Installment
inst:2
Partie
1
Nb partie
2
Application title
PhysioLens: a novel technology to standardize and democratize respiratory research on lung tissue
Application summary
Since the lung is the organ most affected by COVID-19, an increasing number of scientists across the world, with or without specialized knowledge in pulmonology, are searching for means to study the lung tissue using an efficient, biologically-relevant and cost-effective approach. Although this represents a huge engineering challenge, SCIREQ, a Canadian company specialized in respiratory equipment, is rising to the challenge. It is fabricating a new technology, called the physioLens, that is now in the final stages of development and that will enable any scientist to readily undertake experimental studies on isolated lung tissue. SCIREQ is now working with the team of Dr Ynuk Bossé, professor at Laval University and experts in lung physiology, to: 1- optimize, standardize and automate the procedures; 2- undertake validation studies to confirm the usefulness of the technology; and 3- develop new systems to increase the physioLens' versatility and applicability.While enabling the final adjustments before commercialization, this project will also extend the physioLens' capabilities with highly sought-after features that can turn out to be real game changers in respiratory research. This new technology will offer an unprecedented means to study lung tissue in an accurate and reproducible fashion, expediting progress and allowing comparisons between results obtained in different laboratories.In the short term, the physioLens is essential for any scientist seeking a validated and accessible means to study lung tissue. In the long term, it may enable breakthroughs with significant impacts, including the potential to improve patients' care and save lives by accelerating research and drug discovery on COVID-19. Additionally, it will promote a Canadian company, strengthen the link between the academic and private sectors, train highly qualified personnel, keep Canadian lung physiologists at the leading-edge of their field, and contribute to Canada's economic recovery from the pandemic.